• Molecular NameNiflumic Acid
  • Synonym2-(3-(Trifluoromethyl)-phenyl)aminonicotinic acid; 2-(3-(Trifluoromethyl)anilino)nicotinic acid; 2-(3-Trifluoromethyl-phenylamino)-nicotinic acid; 2-(alpha,alpha,alpha-Trifluoro-m-toluidino)nicotinic acid; 2-[(3-Trifluoromethyl)Phenyl]Amino-3-Pyridine-Carboxylic Acid; 2-[3-(Trifluoromethyl)anilino]nicotinic acid; Acide niflumique [inn-french]; Acido niflumico [inn-spanish]; Acidum niflumicum [inn-latin]; Lopac-N-0630; NFA; NFL; Niflumate; Nifluminic acid
  • Weight282.221
  • Drugbank_IDDB04552
  • ACS_NO4394-00-7
  • Show 3D model
  • LogP (experiment)4.81
  • LogP (predicted, AB/LogP v2.0)4.52
  • pkaN/A
  • LogD (pH=7, predicted)2.32
  • Solubility (experiment)0.0191 mg/ml
  • LogS (predicted, ACD/Labs)(ph=7)-1.99
  • LogSw (predicted, AB/LogsW2.0)0.03
  • Sw (mg/ml) (predicted, ACD/Labs)0.03
  • No.of HBond Donors2
  • No.of HBond Acceptors4
  • No.of Rotatable Bonds4
  • TPSA62.22
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyA drug used for joint and muscular pain.
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein bindingN/A
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half lifeN/A
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A